Parallel Trade in Prescription Medicines in the European Union: The Age of Reason?

• Authors: Ian S. Forrester
• Languages of publication: EN
• Publisher: Uniwersytet Warszawski. Wydział Nauk Ekonomicznych
• Journal: Yearbook of Antitrust and Regulatory Studies
• Year: 2008
• Volume: 1(1)
• Pages: 9-31

Dates

published

2008-12-01

Contributors

author

Ian S. Forrester

References

• Behrens H.-P., “Parallelhandelsbeschränkungen und Konsumentenwohlfahrt – Zur neueren Rechtsrechung von EuG und EuGH” (2008) 6 Zeitschrift für Wettbewerbsrecht.
• Calvet H., “Commerce parallèle et droit européen: La fin d’un dogme ?” (2007) 10 Revue Lamy de la Concurrence.
• Chalmers D., Hadjiemmanuil C., Monti. G. and Tomkins A., European Union Law, CUP Cambridge 2006.
• Dawes A., “Neither Head nor Tail: The Confused Application of EC Competition Law to the Pharmaceutical Sector” (2006) 27 European Competition Law Review.
• Dieny E., “Appréciation au regard du droit communautaire de la concurrence d’un accord visant à réduire le commerce parallèle des médicaments” (2006) JCP La Semaine Juridique.
• Eccles R., “Parallel Exports in the Pharmaceuticals Sector: Take Nothing for Granted” (2007) 28 European Competition Law Review
• Forrester, I., “The Dangers of Too Much Precaution” [in:] M. Hoskins, W. Robinson (eds.), A True European: Essays for Judge David Edward, Oxford/Portland, 2003.
• Forrester I., “The Repackaging of Trademarked Pharmaceuticals in Europe: Recent Developments,” paper presented at the Eighth Annual Conference on International Intellectual Property Law and Policy at Fordham University School of Law, April 2000 (2000) 11 European Intellectual Property Review.
• Jenny F., “Pharmaceuticals, Competition and Free Movement of Goods” [in:] EU Competition Law and Policy, Developments and Priorities, Hellenic Competition Committee (ed.), Athens Conference, April 19th 2002, Athens, Nomiki Vivliothiki.
• Junod V., “An End to Parallel Imports of Medicines? Comments on the Judgment of the Court of First Instance in GlaxoWellcome” (2007) 30 World Competition.
• Korah V., Intellectual Property Rights and the EC Competition Rules, Oxford/Portland, 2006.
• Korah V., “Judgment of the Court of First Instance in GlaxoSmithKline” (2007) 6 Competition Law Journal.
• Köning C., Engelmann C., “Parallel Trade Restrictions in the Pharmaceutical Sector on the Test Stand of Article 82 EC: Commentary on the Opinion on Advocate General Jacobs in the Case Syfait/Glaxosmithkline”, (2005) 25 European Competition Law Review.
• Nikpay A., Kjølbye L. and Faull J., “Article 81”, [in:] J. Faull, A. Nikpay (eds.), The EC Law of Competition, Oxford, 2007.
• Rey P., Venit, J.S., “Parallel Trade and Pharmaceuticals: A Policy in Search of Itself” (2004) 29 European Law Review.
• Roth W-H., “Möglichkeiten und Grenzen eines einheitlichen Binnenmarktes für Arzneimittel” [in:] J. Schwarze, U. Becker (eds.), Arzneimittel im Europäischen Binnenmarkt, Europarecht Beiheft 2/2007, Baden-Baden 2007.
• Souto Soubrier L., “The Concept of an Agreement and Beyond: How to Block Parallel Imports of Pharmaceuticals to Protect the Heart of Competition” [in:] G. Amato, C.D. Ehlermann (eds.), EC Competition Law, A Critical Assessment, Oxford/Portland, 2007.
• Smits R., “On Parallel Trade and Preliminary Issues – A Healthy Approach to Competition Law Enforcement?” (2006) 33 Legal Issues of European Integration.
• Stothers C., “Counterfeit Pharmaceuticals Enter The Parallel Supply Chain” (2007) 2 Journal of Intellectual Property Law & Practice.